18F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma
Author:
- 30 July 2016
- journal article
- research article
- Published by Elsevier in PET Clinics
- Vol. 11 (4) , 363-373
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- PET/MR for therapy response evaluation in malignant lymphoma: initial experienceMagnetic Resonance Materials in Physics, Biology and Medicine, 2012
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectBlood, 2010
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0European Journal of Nuclear Medicine and Molecular Imaging, 2009
- Whole-Body MRI, Including Diffusion-Weighted Imaging, for the Initial Staging of Malignant LymphomaInvestigative Radiology, 2009
- Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncologyEuropean Radiology, 2008
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- Variable Problems in LymphomasJournal of Clinical Oncology, 2005
- Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?Annals of Oncology, 2005
- Comparison between 2-deoxy-2-[F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphomaMolecular Imaging and Biology, 2004